Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer

Context: Papillary thyroid cancer (PTC) is the most common endocrine malignancy. The long-term prognosis is generally excellent. Due to a paucity of data, debate exists regarding the benefit of adjuvant radioactive iodine therapy (RAI) for intermediate-risk patients. Objective: The objective of the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2015-04, Vol.100 (4), p.1529-1536
Hauptverfasser:	Ruel, Ewa, Thomas, Samantha, Dinan, Michaela, Perkins, Jennifer M, Roman, Sanziana A, Sosa, Julie Ann
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Carcinoma - mortality Carcinoma - pathology Carcinoma - radiotherapy Carcinoma, Papillary Female Follow-Up Studies Humans Iodine Radioisotopes - therapeutic use Male Middle Aged Original Radiotherapy, Adjuvant Recurrence Severity of Illness Index Survival Analysis Thyroid Cancer, Papillary Thyroid Neoplasms - mortality Thyroid Neoplasms - pathology Thyroid Neoplasms - radiotherapy Thyroidectomy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!